Results for tag: "Eye Infection Drug"

The Eye Infection Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs to treat eye infections. Eye infections can be caused by a variety of bacteria, viruses, fungi, and parasites, and can range from mild to severe. Eye infection drugs are used to treat a variety of conditions, including conjunctivitis, keratitis, and uveitis. These drugs can be administered topically, orally, or intravenously, depending on the severity of the infection. Eye infection drugs are typically prescribed by an ophthalmologist or optometrist, and can be purchased over-the-counter or through a prescription. Commonly prescribed eye infection drugs include antibiotics, antivirals, antifungals, and anti-inflammatory medications. Some companies in the Eye Infection Drug market include Allergan, Bausch + Lomb, Merck, Pfizer, and Novartis. Show Less Read more